[Federal Register Volume 70, Number 194 (Friday, October 7, 2005)]
[Notices]
[Pages 58718-58719]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-20235]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Disease; 
Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Board of Scientific Counselors, NIDDK.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), Title 5 
U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Institute of Diabetes and Digestive and Kidney Diseases, including 
consideration of personnel qualifications and performance, and the 
competence of individual investigators, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Board of Scientific Counselors, NIDDK.
    Date: November 16-17, 2005.
    Open: November 16, 2005, 6 p.m. to 6:20 p.m.
    Agenda: Introductions and Overview.
    Place: National Institutes of Health, Building 5, Room 127, 
Bethesda, MD 20892.
    Closed: November 16, 2005, 6:20 p.m. to 9 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Building 5, Room 127, 
Bethesda, MD 20892.
    Closed: November 17, 2005, 8 a.m. to 5:30 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Building 5, Room 127, 
Bethesda, MD 20892.

[[Page 58719]]

    Contact Person: Marvin C. Gershengorn, MD, Scientific Director, 
Division of Intramural Research, National Institute of Diabetes and 
Digestive and Kidney Diseases, National Institutes of Health, 9000 
Rockville Pike, Bldg. 10, Rm. 9N222, (301) 496-4129.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance into the building by nongovernment 
employees. Persons without a government I.D. will need to show a 
photo I.D. and sign-in at the security desk upon entering the 
building.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: September 27, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-20235 Filed 10-5-05; 8:45 am]
BILLING CODE 4140-01-M